Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans

Recruiting

Phase 1

KlothoSafety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans

Sponsor:

Minicircle

Code:

NCT07216781

Conditions

Healthy Adults

Eligibility Criteria

Sex: All

Age: 23 - 70+

Healthy Volunteers: Accepted

Interventions

Injectable Plasmid Klotho Gene Therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-27. This information was provided to ClinicalTrials.gov by Minicircle on 2025-10-15.